全文获取类型
收费全文 | 14405篇 |
免费 | 938篇 |
国内免费 | 395篇 |
专业分类
耳鼻咽喉 | 324篇 |
儿科学 | 360篇 |
妇产科学 | 139篇 |
基础医学 | 509篇 |
口腔科学 | 143篇 |
临床医学 | 2802篇 |
内科学 | 3554篇 |
皮肤病学 | 56篇 |
神经病学 | 1046篇 |
特种医学 | 808篇 |
外科学 | 1995篇 |
综合类 | 1941篇 |
现状与发展 | 2篇 |
预防医学 | 318篇 |
眼科学 | 74篇 |
药学 | 948篇 |
15篇 | |
中国医学 | 401篇 |
肿瘤学 | 303篇 |
出版年
2024年 | 23篇 |
2023年 | 215篇 |
2022年 | 417篇 |
2021年 | 562篇 |
2020年 | 594篇 |
2019年 | 523篇 |
2018年 | 504篇 |
2017年 | 534篇 |
2016年 | 515篇 |
2015年 | 547篇 |
2014年 | 995篇 |
2013年 | 1035篇 |
2012年 | 857篇 |
2011年 | 911篇 |
2010年 | 758篇 |
2009年 | 726篇 |
2008年 | 712篇 |
2007年 | 671篇 |
2006年 | 638篇 |
2005年 | 549篇 |
2004年 | 417篇 |
2003年 | 416篇 |
2002年 | 301篇 |
2001年 | 262篇 |
2000年 | 222篇 |
1999年 | 171篇 |
1998年 | 186篇 |
1997年 | 182篇 |
1996年 | 133篇 |
1995年 | 146篇 |
1994年 | 126篇 |
1993年 | 95篇 |
1992年 | 89篇 |
1991年 | 72篇 |
1990年 | 72篇 |
1989年 | 77篇 |
1988年 | 65篇 |
1987年 | 34篇 |
1986年 | 50篇 |
1985年 | 60篇 |
1984年 | 61篇 |
1983年 | 19篇 |
1982年 | 36篇 |
1981年 | 37篇 |
1980年 | 25篇 |
1979年 | 28篇 |
1978年 | 9篇 |
1977年 | 16篇 |
1976年 | 15篇 |
1974年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
《Revista brasileira de otorrinolaringologia (English ed.)》2022,88(4):602-606
IntroductionThe Modena bleeding score is a categorical rating scale that allows the assessment of the surgical field in relation to bleeding during endoscopic surgery. It has recently been presented and validated in the field of endoscopic ear surgery by the present authors. The Modena bleeding score provides five grades for rating the surgical field during endoscopic procedures (from grade 1 ? no bleeding to grade 5 ? bleeding that prevents every surgical procedure except those dedicated to bleeding control).ObjectiveThe aim of this study was to validate the Modena bleeding score in the setting of endoscopic sinus surgery.MethodsFifteen three-minute videos of endoscopic sinus surgery procedures (each containing three bleeding situations) were evaluated by 15 specialists, using the Modena bleeding score. Intra and inter-rater reliability were assessed, and the clinical validity of the Modena bleeding score was calculated using a referent standard.ResultsThe data analysis showed an intra-rater reliability ranging from 0.6336 to 0.861. The inter-rater reliability ranged from 0.676 to 0.844. The clinical validity was α = 0.70; confidence limits: 0.64 ? 0.75, corresponding to substantial agreement.ConclusionThe Modena bleeding score is an effective method to score bleeding during endoscopic sinus surgery. Its application in future research could facilitate the performance and efficacy assessment of surgical techniques, materials or devices aimed to bleeding control during endoscopic sinus surgery. 相似文献
4.
Krishna S. Iyer 《Platelets》2020,31(4):474-482
Abstract Platelets are small, anucleated effector cells that play an important role in linking the hemostatic and inflammatory processes in the body. Platelet function is known to be altered under various inflammatory conditions including aging. A gain in platelet function during aging can increase the risk of thrombotic events, such as stroke and acute myocardial infarction. Anti-platelet therapy is designed to reduce risk of serious cerebrovascular and cardiovascular events, but the adverse consequences of therapy, such as risk for bleeding increases with aging as well. Age-associated comorbidities such as obesity, diabetes, and hyperlipidemia also contribute to increased platelet activity and thus can enhance the risk of thrombosis. Therefore, identification of unique mechanisms of platelet dysfunction in aging and in age-associated comorbidities is warranted to design novel antiplatelet drugs. This review outlines some of the current areas of research on aging-related mechanisms of platelet hyperactivity and addresses the clinical urgency for designing anti-platelet therapies toward novel molecular targets in the aging population. 相似文献
5.
目的:对应用低分子肝素钙与奥扎格雷联合对患有脑血栓疾病的患者实施治疗的临床效果进行研究。方法整群选择在该院2012年12月—2014年12月就诊的患有脑血栓疾病的患者86例,随机分为对照组和治疗组,每组43例。采用奥扎格雷对对照组患者实施治疗;采用低分子肝素钙与奥扎格雷联合对治疗组患者实施治疗。对比神经功能缺损评分在药物治疗前后的变化幅度、脑神经功能恢复正常时间和脑血栓药物治疗计划实施总时间、脑血栓疾病药物治疗效果、用药期间的不良反应人数。结果治疗组患者神经功能缺损评分在药物治疗前后的变化幅度明显大于对照组;脑神经功能恢复正常时间(9.66±2.41)d和脑血栓药物治疗计划实施总时间(13.28±2.14)d明显短于对照组(13.62±3.47)、(17.39±3.20)d;脑血栓疾病药物治疗效果(总有效率90.6%)明显优于对照组(总有效率69.8%);用药期间的不良反应人数(1例)明显少于对照组(8例)。结论应用低分子肝素钙与奥扎格雷联合对患有脑血栓疾病的患者实施治疗的临床效果非常明显。 相似文献
6.
7.
8.
9.
Walid K. Abu Saleh Phillip Mason Odeaa Al Jabbari Hany Samir Brian A. Bruckner 《Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital》2015,42(6):569-571
The Impella 5.0, a percutaneously inserted left ventricular assist device, has been used to support patients who have severe heart failure or who are undergoing high-risk percutaneous coronary intervention. We report our surgical placement of the Impella 5.0, through a graft sewn to the aorta, to unload the left ventricle of a 59-year-old man who was undergoing venoarterial extracorporeal membrane oxygenation for postcardiotomy shock. The patient underwent successful placement of a long-term left ventricular assist device before his discharge from the hospital. The versatility of the Impella 5.0 is exemplified in this patient who was successfully bridged to long-term support. 相似文献
10.